Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
INMD
STRONG BUYFLAGInMode Ltd. · Healthcare · Israel · $763M · Avg Vol: $13M/d
InMode is an incredibly profitable medical aesthetics company with high margins and a strong cash position (Q: 80). However, it is facing a cyclical slowdown in consumer discretionary spending on high-end aesthetic procedures and geopolitical headwinds in Israel, which cloud the near-term outlook.
COMPANY DESCRIPTION
InMode Ltd. develops, manufactures, and markets a range of minimally invasive aesthetic medical devices that utilize proprietary radio-frequency (RF) technology for skin remodeling, fat reduction, and other cosmetic procedures. The company's competitive moat is derived from its innovative, patented technology and focus on less invasive solutions, positioning it as a fast-growing player driving advancements in the global medical aesthetics market.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR |
|---|---|---|---|---|---|
| Revenue | 454.3M | 492.0M | 394.8M | 370.5M | -6.6% |
| EPS | 1.96 | 2.37 | 2.29 | 1.45 | -9.6% |
| Shares | 84.5M | 86.0M | 87.6M | 88.3M | +4.5% |
| Debt | 5.0M | 9.0M | 7.8M | 8.2M | 18.4% |
| Equity | 554.6M | 787.4M | 703.8M | 683.2M | 7.2% |
| Op CF | 181.6M | 176.8M | 132.7M | 85.3M | -22.3% |
| Inv CF | -109.5M | -136.1M | 162.2M | 186.0M | — |
| Fin CF | -41.1M | 5.5M | -282.8M | -126.1M | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of INMD are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| INMD | InMode Ltd.(you) | $763M | 98 | STRONG BUY |
| BWAY | BrainsWay Ltd. | $585M | 83 | STRONG BUY |
| 1696.HK | Sisram Medical Ltd | $134M | 64 | HOLD |
| KMDA | Kamada Ltd. | $410M | 95 | STRONG BUY |
| NNOX | Nano-X Imaging Ltd. | $112M | 8 | STRONG SELL |
| CGEN | Compugen Ltd. | $196M | 93 | STRONG BUY |
| DRTS | Alpha Tau Medical Ltd. | $890M | 36 | HOLD |
| SLGL | Sol-Gel Technologies Ltd. | $246M | 39 | HOLD |
| BVC.L | BATM Advanced Communications Ltd. | $69M | 56 | HOLD |
| ENLV | Enlivex Ltd. | $146M | 18 | STRONG SELL |
Peer medians: ROE 1.1% · P/E 14.2x · Gross margin 20.9%